JOH | Predictive Factors for Hepatitis Flares after Stopping Nucleos(t)ide Analogs
According to the World Health Organization (WHO), approximately 296 million people globally suffer from chronic hepatitis B (CHB). Despite the advent of new therapies, long-term treatment with nucleos(t)ide analogs (NAs)…